These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36708461)

  • 1. Effects of Simulated Gastrointestinal Conditions on Combined Potentially Probiotic Limosilactobacillus fermentum 296, Quercetin, and/or Resveratrol as Bioactive Components of Novel Nutraceuticals.
    Sampaio KB; de Brito Alves JL; do Nascimento YM; Tavares JF; da Silva MS; Dos Santos Nascimento D; de Araújo Rodrigues NP; Monteiro MC; Garcia EF; de Souza EL
    Probiotics Antimicrob Proteins; 2024 Feb; 16(1):308-319. PubMed ID: 36708461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in vitro evaluation of novel nutraceutical formulations composed of Limosilactobacillus fermentum, quercetin and/or resveratrol.
    Sampaio KB; do Nascimento YM; Tavares JF; Cavalcanti MT; de Brito Alves JL; Garcia EF; de Souza EL
    Food Chem; 2021 Apr; 342():128264. PubMed ID: 33041168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Stability of a Novel Nutraceutical Formulation Combining Probiotic Limosilactobacillus fermentum 296, Quercetin, and Resveratrol Under Different Storage Conditions.
    Dos Santos Nascimento D; Sampaio KB; do Nascimento YM; de Souza TA; de Souza FS; Júnior JVC; Tavares JF; da Silva MS; de Brito Alves JL; de Souza EL
    Probiotics Antimicrob Proteins; 2024 Feb; 16(1):13-25. PubMed ID: 36417111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceutical formulations combining Limosilactobacillus fermentum, quercetin, and or resveratrol with beneficial impacts on the abundance of intestinal bacterial populations, metabolite production, and antioxidant capacity during colonic fermentation.
    Brito Sampaio K; Luiz de Brito Alves J; Mangueira do Nascimento Y; Fechine Tavares J; Sobral da Silva M; Dos Santos Nascimento D; Dos Santos Lima M; Priscila de Araújo Rodrigues N; Fernandes Garcia E; Leite de Souza E
    Food Res Int; 2022 Nov; 161():111800. PubMed ID: 36192946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota.
    da Silva JYP; do Nascimento HMA; de Albuquerque TMR; Sampaio KB; Dos Santos Lima M; Monteiro M; Leite IB; da Silva EF; do Nascimento YM; da Silva MS; Tavares JF; de Brito Alves JL; de Oliveira MEG; de Souza EL
    Probiotics Antimicrob Proteins; 2024 Oct; 16(5):1773-1789. PubMed ID: 37561381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Quercetin and Resveratrol on
    Dos Santos AS; de Albuquerque TMR; de Brito Alves JL; de Souza EL
    Front Microbiol; 2019; 10():2229. PubMed ID: 31608042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of physiological responses of potentially probiotic fruit-derived Limosilactobacillus fermentum in apple and orange juices during refrigeration storage and exposure to simulated gastrointestinal conditions.
    Rodrigues NPA; Garcia EF; Sampaio KB; do Nascimento HMA; de Sousa Guedes JP; de Souza EL
    Arch Microbiol; 2021 Dec; 204(1):38. PubMed ID: 34928420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limosilactobacillus fermentum Strains as Novel Probiotic Candidates to Promote Host Health Benefits and Development of Biotherapeutics: A Comprehensive Review.
    de Luna Freire MO; Cruz Neto JPR; de Albuquerque Lemos DE; de Albuquerque TMR; Garcia EF; de Souza EL; de Brito Alves JL
    Probiotics Antimicrob Proteins; 2024 Aug; 16(4):1483-1498. PubMed ID: 38393628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limosilactobacillus fermentum Strains with Claimed Probiotic Properties Exert Anti-oxidant and Anti-inflammatory Properties and Prevent Cardiometabolic Disorder in Female Rats Fed a High-Fat Diet.
    de Luna Freire MO; do Nascimento LCP; de Oliveira KÁR; de Oliveira AM; Dos Santos Lima M; Napoleão TH; da Costa Silva JH; Lagranha CJ; de Souza EL; de Brito Alves JL
    Probiotics Antimicrob Proteins; 2023 Jun; 15(3):601-613. PubMed ID: 34817804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially Probiotic Limosilactobacillus fermentum Fruit-Derived Strains Alleviate Cardiometabolic Disorders and Gut Microbiota Impairment in Male Rats Fed a High-Fat Diet.
    de Araújo Henriques Ferreira G; Magnani M; Cabral L; Brandão LR; Noronha MF; de Campos Cruz J; de Souza EL; de Brito Alves JL
    Probiotics Antimicrob Proteins; 2022 Apr; 14(2):349-359. PubMed ID: 35066820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety Evaluation of a Novel Potentially Probiotic Limosilactobacillus fermentum in Rats.
    Cruz Neto JPR; de Oliveira AM; de Oliveira KÁR; Sampaio KB; da Veiga Dutra ML; de Luna Freire MO; de Souza EL; de Brito Alves JL
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):752-762. PubMed ID: 37119497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactobacillus casei and Lactobacillus fermentum Strains Isolated from Mozzarella Cheese: Probiotic Potential, Safety, Acidifying Kinetic Parameters and Viability under Gastrointestinal Tract Conditions.
    de Souza BMS; Borgonovi TF; Casarotti SN; Todorov SD; Penna ALB
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):382-396. PubMed ID: 29542032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effects of
    Rodríguez-Sojo MJ; Garcia-Garcia J; Ruiz-Malagón AJ; Diez-Echave P; Hidalgo-García L; Molina-Tijeras JA; González-Lozano E; López-Escanez L; Rodríguez-Cabezas ME; Rodríguez-Sánchez MJ; Rodríguez-Nogales A; Mediavilla C; Galvez J
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limosilactobacillus fermentum, Current Evidence on the Antioxidant Properties and Opportunities to be Exploited as a Probiotic Microorganism.
    Paulino do Nascimento LC; Lacerda DC; Ferreira DJS; de Souza EL; de Brito Alves JL
    Probiotics Antimicrob Proteins; 2022 Oct; 14(5):960-979. PubMed ID: 35467236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adherence and anti-infective properties of probiotic Lactobacillus fermentum strain 4-17 against Escherichia coli causing urinary tract infection in humans.
    Falah F; Vasiee A; Behbahani BA; Yazdi FT; Moradi S; Mortazavi SA; Roshanak S
    Microb Pathog; 2019 Jun; 131():246-253. PubMed ID: 30974159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete genome analysis of Lactobacillus fermentum YLF016 and its probiotic characteristics.
    Zhang L; Ma H; Kulyar MF; Pan H; Li K; Li A; Mo Q; Wang Y; Dong H; Bao Y; Li J
    Microb Pathog; 2022 Jan; 162():105212. PubMed ID: 34597776
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zafar H; Ain NU; Alshammari A; Alghamdi S; Raja H; Ali A; Siddique A; Tahir SD; Akbar S; Arif M; Alharbi M; Rahman A
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458216
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ozen M; Piloquet H; Schaubeck M
    Nutrients; 2023 May; 15(9):. PubMed ID: 37432320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligosaccharides as co-encapsulating agents: effect on oral Lactobacillus fermentum survival in a simulated gastrointestinal tract.
    Liao N; Luo B; Gao J; Li X; Zhao Z; Zhang Y; Ni Y; Tian F
    Biotechnol Lett; 2019 Feb; 41(2):263-272. PubMed ID: 30535881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ameliorating effect of limosilactobacillus fermentum and its supernatant postbiotic on cisplatin-induced chronic kidney disease in an animal model.
    Gholami A; Montazeri-Najafabady N; Ashoori Y; Kazemi K; Heidari R; Omidifar N; Karimzadeh I; Ommati MM; Abootalebi SN; Golkar N
    BMC Complement Med Ther; 2023 Jul; 23(1):243. PubMed ID: 37461012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.